Market Place
Sourcing Support
Lupin Launches Generic Anti-Diabetic Tablets In US
22 Apr 2026 //
ECONOMICTIMES
FDA signs off on generics for AstraZeneca`s Farxiga
13 Apr 2026 //
FDA
Lupin Launches Dapagliflozin Tablets In The United States
10 Apr 2026 //
PR NEWSWIRE
Inventia’s Generics Dapagliflozin Receives Tentative Nod in US
09 Apr 2026 //
FDA
Lupin Gets ANDA Approval For Dapagliflozin, Metformin Er Tablets
09 Apr 2026 //
EXPRESSPHARMA
U.S. FDA Approves Generic Dapagliflozin for India
09 Apr 2026 //
INDPHARMAPOST
Lupin Gets FDA Approval For Dapagliflozin Tablets In US
07 Apr 2026 //
PR NEWSWIRE
Alembic Pharma Gets USFDA Nod For Dapagliflozin Tablets
07 Apr 2026 //
EXPRESSPHARMA
Lupin’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Alkem’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Sun Pharm’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Micro’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Teva’ Generics Dapagliflozin And Metformin Receives nod in US
06 Apr 2026 //
FDA
Macleods’ Generics Dapagliflozin & Metformin Receives nod in US
06 Apr 2026 //
FDA
Torrent’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin & Metformin Receive Approval in US
06 Apr 2026 //
FDA
Cipla’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Msn’s Generics Dapagliflozin & Saxagliptin Receive Approval in US
06 Apr 2026 //
FDA
Lupin’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Aizant’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin & Metformin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Bion Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Aurobindo Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Micro’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Sandoz’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets
05 Feb 2026 //
EXPRESSPHARMA
Zydus’ Generics Dapagliflozin Receives Tentative Approval in US
02 Feb 2026 //
FDA
ScieGen’s Generics Dapagliflozin Receive Tentative Approval in US
08 Jan 2026 //
FDA
Alkem’s Generics Dapagliflozin Receives Tentative Approval in US
02 Jan 2026 //
FDA
Hansoh’s Generics Dapagliflozin Receives Tentative Approval in US
23 Dec 2025 //
FDA
Teva’ Generics Dapagliflozin Receives Tentative Approval in US
18 Dec 2025 //
FDA
Aurobindo’s Generics Dapagliflozin Receives Approval in US
10 Dec 2025 //
FDA
Alembic Pharms’ Generics Dapagliflozin Receives Approval in US
24 Nov 2025 //
FDA
Inventia Hlthcare Generics Dapagliflozin Receives Approval in US
21 Nov 2025 //
FDA
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
National Pharmaceutical Pricing Authority Sets Retail Prices
06 Nov 2025 //
PHARMABIZ
Center for Development and Production of Highly Potent Drugs
23 Oct 2025 //
PRESS RELEASE
Success in the development of the medicinal product Dapagliflozin
23 Oct 2025 //
PRESS RELEASE
Macleods’s Dapagliflozin Receives Tentative Approval in US
15 Oct 2025 //
FDA
Lilly`s Orforglipron Shows Superior Glycemic Control In Phase 3
15 Oct 2025 //
PR NEWSWIRE
Ajanta’s Generics Dapagliflozin Receives Tentative Approval in US
14 Oct 2025 //
FDA
Astrazeneca Debuts DTC Service With Discounted Farxiga, Airsupra
26 Sep 2025 //
FIERCE PHARMA
MSN’s Generics Dapagliflozin Receive Tentative Approval in US
05 Sep 2025 //
FDA
NHS Spends £1.92 Billion on Diabetes Treatment with New Meds
21 Aug 2025 //
PHARMAWEB
LG Chem sets sights on global market with launch Zemidapa
14 May 2025 //
INDPHARMAPOST
Nectar Life Care introduces affordable anti-diabetic medications
18 Feb 2025 //
EXPRESSPHARMA
Nectar Life Care Launches Affordable Anti-Diabetic Drug Range
17 Feb 2025 //
INDPHARMAPOST
Akums combines 2 potent diabetes medicines for treatment efficacy
04 Feb 2025 //
INDPHARMAPOST
Parand Darou’s Commitment to Diabetes Management
23 Nov 2024 //
PRESS RELEASE
Farxiga approved in the US for the treatment of paediatric type-2 diabetes
13 Jun 2024 //
PRESS RELEASE
AstraZeneca champions early kidney disease diagnosis with modelling data
11 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
AstraZeneca aims for $80 bln in total revenue by 2030
21 May 2024 //
REUTERS
AstraZeneca beats revenue, profit estimates on resilient demand
25 Apr 2024 //
REUTERS
AstraZeneca cries havoc over CKD`s hit on economies, environment
15 Apr 2024 //
FIERCE PHARMA
TheracosBio`s BRENZAVVY® Non-Inferior To Dapagliflozin
12 Apr 2024 //
BUSINESSWIRE
Zydus Pharma`s Generic Dapagliflozin Receives Approval in the U.S.
28 Feb 2024 //
FDA
Zibotentan/dapagliflozin combination showed albuminuria reduction in patients
03 Nov 2023 //
BUSINESSWIRE
Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
18 Oct 2023 //
INDIAN PHARMA POST
